Charles Schwab’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Sell |
354,439
-25,972
| -7% | -$153K | ﹤0.01% | 2654 |
|
|
2025
Q1 | $3.19M | Buy |
380,411
+30,901
| +9% | +$259K | ﹤0.01% | 2459 |
|
|
2024
Q4 | $2.6M | Sell |
349,510
-41,523
| -11% | -$309K | ﹤0.01% | 2599 |
|
|
2024
Q3 | $2.27M | Buy |
391,033
+17,783
| +5% | +$103K | ﹤0.01% | 2667 |
|
|
2024
Q2 | $2.48M | Buy |
373,250
+14,900
| +4% | +$99.1K | ﹤0.01% | 2629 |
|
|
2024
Q1 | $4.68M | Buy |
358,350
+2,530
| +0.7% | +$33K | ﹤0.01% | 2310 |
|
|
2023
Q4 | $4.54M | Buy |
355,820
+19,571
| +6% | +$250K | ﹤0.01% | 2353 |
|
|
2023
Q3 | $4.41M | Buy |
336,249
+51,892
| +18% | +$680K | ﹤0.01% | 2311 |
|
|
2023
Q2 | $7.27M | Buy |
284,357
+21,119
| +8% | +$540K | ﹤0.01% | 2061 |
|
|
2023
Q1 | $6.63M | Buy |
263,238
+24,151
| +10% | +$608K | ﹤0.01% | 2065 |
|
|
2022
Q4 | $5.5M | Buy |
239,087
+5,208
| +2% | +$120K | ﹤0.01% | 2165 |
|
|
2022
Q3 | $5.16M | Buy |
233,879
+101,106
| +76% | +$2.23M | ﹤0.01% | 2203 |
|
|
2022
Q2 | $1.9M | Buy |
132,773
+7,052
| +6% | +$101K | ﹤0.01% | 2578 |
|
|
2022
Q1 | $2.38M | Buy |
125,721
+3,265
| +3% | +$61.8K | ﹤0.01% | 2585 |
|
|
2021
Q4 | $2.28M | Buy |
122,456
+41,867
| +52% | +$781K | ﹤0.01% | 2662 |
|
|
2021
Q3 | $2.17M | Buy |
80,589
+1,832
| +2% | +$49.3K | ﹤0.01% | 2683 |
|
|
2021
Q2 | $2.46M | Buy |
+78,757
| New | +$2.46M | ﹤0.01% | 2640 |
|